Resources and tools for rare disease variant interpretation

Front Mol Biosci. 2023 May 10:10:1169109. doi: 10.3389/fmolb.2023.1169109. eCollection 2023.

Abstract

Collectively, rare genetic disorders affect a substantial portion of the world's population. In most cases, those affected face difficulties in receiving a clinical diagnosis and genetic characterization. The understanding of the molecular mechanisms of these diseases and the development of therapeutic treatments for patients are also challenging. However, the application of recent advancements in genome sequencing/analysis technologies and computer-aided tools for predicting phenotype-genotype associations can bring significant benefits to this field. In this review, we highlight the most relevant online resources and computational tools for genome interpretation that can enhance the diagnosis, clinical management, and development of treatments for rare disorders. Our focus is on resources for interpreting single nucleotide variants. Additionally, we present use cases for interpreting genetic variants in clinical settings and review the limitations of these results and prediction tools. Finally, we have compiled a curated set of core resources and tools for analyzing rare disease genomes. Such resources and tools can be utilized to develop standardized protocols that will enhance the accuracy and effectiveness of rare disease diagnosis.

Keywords: genetic disorder; genome interpretation; genotype-phenotype association; machine learning; precision medicine; rare disease; single nucleotide variant (SNV).

Publication types

  • Review

Grants and funding

This work was supported by the following PRIN projects of the Ministero Istruzione, Università e Ricerca: “Integrative tools for defining the molecular basis of the diseases: Computational and Experimental methods for Protein Variant Interpretation” (PRIN201744NR8S), “Protein Bioinformatics for Human Health” (PRIN2017483NH8). DG is supported within the framework of CIR01_00017–“CNRBiOmics–Centro Nazionale di Ricerca in Bioinformatica per le Scienze Omiche”–Rafforzamento del capitale umano–CUP B56J20000960001.